| Inhibitor of growth 4 induces apoptosis in human lung adenocarcinoma cell line A549 via Bcl-2 family proteins and mitochondria apoptosis pathway. | |
| | |
MedLine Citation:
|
PMID: 19034511 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Inhibitor of growth 4 (ING4) is considered to be a tumor suppressor implicated in several human malignancies by tumor growth inhibition and apoptosis enhancement. In present study, the effects of ING4 on apoptosis and its mechanisms were investigated through the transduction of ING4 cDNA into lung adenocarcinoma cell line A549. METHODS: The effects of ING4 on A549 apoptosis were observed by FCM analysis, TUNEL assay, and electron microscopy. Simultaneously, the effects of ING4 on the expression of several apoptosis-related proteins in cell line A549 were evaluated by Western blot analysis. RESULTS: Both Annexin-V FITC analysis by FCM and TUNEL assay revealed more apoptotic cells in A549 cells with exogenous ING4 gene. For electron microscopy, A549 cells with exogenous ING4 gene showed typical morphological changes of apoptosis. The deregulation of Bcl-2 family proteins (Bcl-2, Bcl-xl, Bax, Bak, Bid) and the major apoptotic executioners of mitochondria pathway (Cyt-c, caspase3, PARP) were also observed. CONCLUSION: Our findings suggest that exogenous ING4 can enhance A549 apoptosis via regulating the expression of Bcl-2 family proteins and the activation of mitochondrial apoptotic pathway. |
| | |
Authors:
|
Xiaomei Li; Qingyuan Zhang; Limin Cai; Yanhua Wang; Qian Wang; Xiaoyi Huang; Songbin Fu; Jing Bai; Jinglei Liu; Guangmei Zhang; Jiping Qi |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2008-11-26 |
Journal Detail:
|
Title: Journal of cancer research and clinical oncology Volume: 135 ISSN: 1432-1335 ISO Abbreviation: J. Cancer Res. Clin. Oncol. Publication Date: 2009 Jun |
Date Detail:
|
Created Date: 2009-04-30 Completed Date: 2009-05-28 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7902060 Medline TA: J Cancer Res Clin Oncol Country: Germany |
Other Details:
|
Languages: eng Pagination: 829-35 Citation Subset: IM |
Affiliation:
|
Department of Pathology, The Affiliated Tumor Hospital of Harbin Medical University, Harbin 150040, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adenocarcinoma
/
metabolism,
pathology,
physiopathology* Animals Apoptosis / physiology* Blotting, Western Caspase 3 / metabolism Cell Cycle Proteins / genetics, metabolism, physiology* Cell Line, Tumor Cytochromes c / metabolism Flow Cytometry Homeodomain Proteins / genetics, metabolism, physiology* Humans Immunohistochemistry In Situ Nick-End Labeling Lung / metabolism, pathology, ultrastructure Lung Neoplasms / metabolism, pathology, physiopathology* Male Mice Mice, Inbred BALB C Mice, Nude Microscopy, Electron Mitochondria / metabolism* Neoplasm Transplantation Proto-Oncogene Proteins c-bcl-2 / metabolism* Signal Transduction / physiology Transfection Transplantation, Heterologous Tumor Suppressor Proteins / genetics, metabolism, physiology* |
| Chemical | |
Reg. No./Substance:
|
0/Cell Cycle Proteins; 0/Homeodomain Proteins; 0/ING4 protein, human; 0/Proto-Oncogene Proteins c-bcl-2; 0/Tumor Suppressor Proteins; 9007-43-6/Cytochromes c; EC 3.4.22.-/Caspase 3 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Expression of stathmin/op18 as a significant prognostic factor for cervical carcinoma patients.
Next Document: Incidence of joint symptoms and bone fractures in Japanese postmenopausal breast cancer patients tre...